Treatment with combined oral contraceptives induces a rise in serum C‐reactive protein in the absence of a general inflammatory response
Open Access
- 13 December 2005
- journal article
- research article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 4 (1), 77-82
- https://doi.org/10.1111/j.1538-7836.2005.01690.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Elevated Serum C-Reactive Protein Levels and Advanced Atherosclerosis in YouthArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- C-Reactive Protein Attenuates Endothelial Progenitor Cell Survival, Differentiation, and FunctionCirculation, 2004
- Sex hormone–binding globulin—A surrogate marker for the prothrombotic effects of combined oral contraceptivesAmerican Journal of Obstetrics and Gynecology, 2004
- Third generation oral contraceptive use and cardiovascular risk factorsAtherosclerosis, 2004
- Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) StudyStroke, 2002
- Generation of C-Reactive Protein and Complement Components in Atherosclerotic PlaquesThe American Journal of Pathology, 2001
- Autoantibodies to OxLDL Are Decreased in Individuals With Borderline HypertensionHypertension, 1999
- Serum Total IGF-I, Free IGF-I, and IGFBP-1 Levels in an Elderly PopulationArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Insulin-like growth factor-1 and angiographically documented coronary artery diseaseThe American Journal of Cardiology, 1996
- A Prospective Study of Past Use of Oral Contraceptive Agents and Risk of Cardiovascular DiseasesNew England Journal of Medicine, 1988